Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 2002

View Archived Issues

Potential new therapeutic agent for arterial thrombosis discovered in Taiwan

Pleconaril reported to be safe and effective for picornavirus-associated viral respiratory illness

GRP promotes keratinocyte proliferation and wound healing in vitro and in vivo

New data on the antitumor effects of the monoclonal antibody IMC-C225

IND submitted for IL-4/13 Trap in asthma patients

Variagenics conducts pharmacogenomic evaluation of pravastatin trial

Isis continues to make steady progress in clinical development and drug discovery

Coviracil phase III interim results

Marketing authorization for Triacelluvax withdrawn in E.U.

Zonagen receives SBIR grant to study adjuvant system

IND submitted for NT-13

Risperdal Consta approved in Germany

Lilly and Elan jointly describe a novel inhibitor of Abeta synthesis and/or release

Senju presents new calpain inhibitors for stroke, ocular disorders, etc.

Wyeth claims dual inhibitors of 5-HT1A/5-HT reuptake

Roche and Vernalis claim novel 5-HT2C receptor agonists with potential in obesity and diabetes

New CDK inhibitors emerge from Pharmacia R&D

New factor Xa/factor VIIa inhibitors in early development at Merck

Antitumor compound from natural source identified at Pharma Mar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...